Amundi Asset Management US’s Halozyme HALO Stock Holding History

Amundi Asset Management US’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$247K	Sell	5,929 -6,271	-51%	-$286K	﹤0.01%	1445
2020 Q4	$521K	Hold	12,200	–	–	﹤0.01%	1287
2020 Q3	$321K	Hold	12,200	–	–	﹤0.01%	1313
2020 Q2	$327K	Hold	12,200	–	–	﹤0.01%	1311
2020 Q1	$219K	Hold	12,200	–	–	﹤0.01%	1318
2019 Q4	$216K	Hold	12,200	–	–	﹤0.01%	1452
2019 Q3	$189K	Buy	12,200 +2,600	+27%	+$42.8K	﹤0.01%	1470
2019 Q2	$165K	Hold	9,600	–	–	﹤0.01%	1506
2019 Q1	$155K	Hold	9,600	–	–	﹤0.01%	1480
2018 Q4	$140	Buy	+9,600	New	+$153K	﹤0.01%	1452

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amundi Asset Management US's HALO Position: Q1 2021 in Review

Amundi Asset Management US reduced its Halozyme (HALO) stake by 51% in Q1 2021, selling an estimated $286K and leaving 5,929 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Amundi Asset Management US first reported a position in HALO in Q4 2018 and has held it in 10 quarters since. The position peaked at $521K in Q4 2020. 337 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

Amundi Asset Management US held 5,929 shares of Halozyme worth $247K as of Q1 2021.
Amundi Asset Management US sold 6,271 Halozyme shares in Q1 2021, an estimated $286K.
Halozyme made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1445 holding.
Amundi Asset Management US first reported a position in Halozyme in Q4 2018 and has held it in 10 quarters since.
Amundi Asset Management US's Halozyme position peaked at $521K in Q4 2020.
337 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.